Selecting an optimal cutoff value for creatinine in the model for end-stage liver disease equation
β Scribed by Teh-Ia Huo; Chia-Yang Hsu; Han-Chieh Lin; Pui-Ching Lee; Jing-Yi Lee; Fa-Yauh Lee; Ming-Chih Hou; Shou-Dong Lee
- Book ID
- 110890239
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 157 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0902-0063
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Renal function has a significant impact on early mortality in patients with cirrhosis. However, creatinine and creatinine-based equations are inaccurate markers of renal function in cirrhosis. The aim of this study was to reassess correlations between creatinine-based equations and measured glomerul
With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant
We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import
Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific